MADELINE PEREZ-ANDRADE: Open Payments
NPI 1639841869 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 18 payments from 10 companies in 2025. Trend: 2023 $331 · 2024 $598 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $141 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| CeQur Corporation | 1 | $121 |
| BETA BIONICS, INC. | 4 | $118 |
| Sequel Med Tech, LLC | 5 | $104 |
| Tandem Diabetes Care, Inc. | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Antares Pharma, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $25 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
Products named: OMNIPOD, GVOKE HYPOPEN, CeQur Simplicity, iLet Bionic Pancreas, TWIIST, t:slim X2 Insulin Pump with Control-IQ, LEQVIO, XYOSTED.
Industry payments across CA — which companies pay providers there.
